Meningococcal arthritis
ICD-10 A39.83 is a billable code used to indicate a diagnosis of meningococcal arthritis.
Meningococcal arthritis is a rare but serious complication of meningococcal infection, which is caused by the bacterium Neisseria meningitidis. This condition typically arises when the bacteria invade the bloodstream and subsequently infect the joints, leading to inflammation and pain. Patients may present with acute onset of joint pain, swelling, and fever, often accompanied by systemic symptoms of meningococcal disease such as rash, headache, and neck stiffness. Diagnosis is primarily clinical, supported by laboratory tests including blood cultures and joint aspiration to identify the causative organism. Treatment involves prompt administration of appropriate antibiotics, such as penicillin or ceftriaxone, and may require joint drainage in cases of significant effusion. Early recognition and intervention are crucial to prevent long-term joint damage and systemic complications. Meningococcal arthritis is more common in children and adolescents, particularly in those with underlying immunocompromised states or asplenia. The prognosis is generally favorable with timely treatment, although some patients may experience residual joint issues.
Detailed clinical history, laboratory results, and treatment protocols.
Patients presenting with fever and joint pain, particularly in outbreak settings.
Need for rapid identification of the causative organism and appropriate antibiotic therapy.
Comprehensive assessment of joint involvement and response to treatment.
Patients with joint swelling and systemic symptoms requiring differentiation from other arthritides.
Documentation of any residual joint damage or chronic arthritis post-infection.
Used when joint effusion is present and requires drainage.
Document the indication for the procedure and the findings from the aspiration.
Rheumatologists should document the clinical rationale for the procedure.
Common symptoms include sudden onset of joint pain, swelling, fever, and systemic signs such as rash and headache.
Treatment typically involves intravenous antibiotics and may include joint drainage if there is significant effusion.
With prompt treatment, the prognosis is generally good, although some patients may experience residual joint issues.
